Retatrutide
Few metabolic tool compounds engage as many pathways at once as Retatrutide. This synthetic peptide acts as a triple incretin receptor agonist, hitting the GLP-1, GIP and glucagon receptors in parallel — a mechanism that places it among the most intricate agonists available for preclinical metabolic signalling work.
Supplied as a lyophilised powder across six vial sizes, every batch reaches ≥99% purity confirmed by HPLC, with a Certificate of Analysis available on request. Dispatched from a UK-based facility for laboratory and research use only.
Order before 12pm for same-day dispatch — Royal Mail 24, next-day UK delivery.
- Simultaneous GLP-1R / GIPR / glucagon receptor agonism assays
- Energy homeostasis and metabolic pathway modelling
- Receptor engagement comparisons against single- and dual-agonist peptides
- Gut-brain axis and appetite-signalling investigations
For laboratory research use only. Not for human or veterinary use.
- Form: Lyophilised powder
- Purity: ≥99% (HPLC verified)
- Storage: −20°C, protected from light and moisture
- Available sizes: 10mg · 20mg · 30mg · 40mg · 50mg · 60mg
- Certificate of Analysis: available on request